Evaluating Clareon PanOptix outcomes in cataract patients with prior myopic surgery
Official title: Visual and Refractive Outcomes of the Clareon PanOptix Pro IOL in Patients With Prior Myopic Refractive Surgery
Run by Juliette Eye Institute Research Center · NCT06555289 · Data updated 2026-11-12
This study is testing how well the Clareon PanOptix lenses work for people with cataracts who have had previous eye surgery to see if they improve vision after surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Juliette Eye Institute Research Center Academic / other |
| Locations | 1 site (Albuquerque, New Mexico) |
| Status | Recruiting |
| Started | October 23, 2024 |
| Main results expected | September 1, 2026 |
| Study ends | September 1, 2026 |
| Registry record updated | December 12, 2025 |
| Trial ID | NCT06555289 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 45 and older with age-related cataracts and a history of myopic PRK or LASIK.
✕Probably not a fit
Patients with significant ocular comorbidities or those who do not meet the inclusion criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on the clinical outcomes of patients undergoing bilateral cataract surgery with the implantation of Clareon PanOptix intraocular lenses (IOL). Participants will be assessed before surgery and at one and three months post-surgery, with evaluations including visual acuity measurements and questionnaire assessments. The study aims to gather data on the effectiveness of the PanOptix IOL in patients who have previously undergone myopic refractive surgery. It is a single-center, single-arm study designed to provide insights into postoperative visual outcomes.
Why it matters
Potential benefit: If successful, this study could enhance understanding of how Clareon PanOptix IOLs perform in patients with a history of myopic refractive surgery, potentially leading to improved surgical outcomes.
How similar studies have gone: While this approach is observational, similar studies have shown promising outcomes with advanced IOLs in cataract surgery, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (45 years or older) who have confirmed age-related cataracts and are eligible for bilateral cataract surgery. * Prior binocular myopic photorefractive keratectomy (PRK) or myopic LASIK. * Patients who have regular corneal astigmatism less than or equal to 0.6 D and are candidates for the PanOptix Pro spherical IOL. * Patients who have regular corneal astigmatism and are candidates for PanOptix Pro toric IOL T3 * Postoperative visual potential of monocular 20/25 or better, in the surgeon's judgement. Exclusion Criteria: * Any ocular comorbidity that might hamper postoperative visual acuity: * Corneal abnormality including corneal dystrophy, irregularity, and degeneration. * Moderate or severe dry eyes that can't be relieved after treatment. * History of or current anterior and posterior inflammation of any etiology. * Retinal pathology such as AMD, diabetic retinopathy, vein occlusion, etc. * Glaucoma of any kind. * Pregnancy or lactation. * Any ocular surgery other than corneal myopic refractive surgery (LASIK and PRK). * Patients with physical or intellectual disability (e.g. Down's Syndrome, Parkinson's Disease, unable to fixate) * Apple Kappa/chord mu ≥ 0.6. * Higher order corneal aberrations at pupil diameter of 4mm: \> 0.6 total RMS, \> 0.3 coma, \> 0.3 trefoil (to exclude irregular corneas) * Any patient requiring a limbal relaxing incision. The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.
Where it's running
-
Juliette Eye Institute Research Center
Albuquerque, New Mexico, United States Recruiting
Study contacts
- Principal investigator: Robert Melendez, MD, MBA — Juliette Eye Institute Research Center
- Study coordinator: Zoe Baker, OD
- Email: dr.baker@julietteeye.com
- Phone: 505-355-2020
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.